Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fuellen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|December 26, 2001
Minimum conflict: a divide-and-conquer approach to phylogeny estimationG Fuellen, J W Wägele, R Giegerich
Biochemical Society Transactions|March 30, 2004
Phylogenomics of hyperthermophilic Archaea and BacteriaH-P Klenk, M Spitzer, T Ochsenreiter, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
Distance education through the Internet: the GNA-VSNS biocomputing courseF M de la Vega, R Giegerich, G Fuellen
Cancer Cell International|August 21, 2020
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell linesL-M Sklarz, Y S Gladbach, M Ernst, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|December 26, 2001
Minimum conflict: a divide-and-conquer approach to phylogeny estimationG Fuellen, J W Wägele, R Giegerich
Biochemical Society Transactions|March 30, 2004
Phylogenomics of hyperthermophilic Archaea and BacteriaH-P Klenk, M Spitzer, T Ochsenreiter, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
Distance education through the Internet: the GNA-VSNS biocomputing courseF M de la Vega, R Giegerich, G Fuellen
Cancer Cell International|August 21, 2020
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell linesL-M Sklarz, Y S Gladbach, M Ernst, et al.
Pageof 1